GENEVA, Aug. 12 -- ENSEM THERAPEUTICS, INC (880 Winter Street, Suite 1003Waltham, MA 02451) filed a patent application (PCT/US2025/013543) for "GUANIDINO TRICYCLIC COMPOUNDS, AND COMPOSITIONS AND METHODS THEREOF" on Jan 29, 2025. With publication no. WO/2025/165839, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LI, Mingzong (880 Winter Street, Suite 1003Waltham, MA 02451), LIU, Tao (880 Winter Street, Suite 1003Waltham, MA 02451)
Abstract:
The invention provides novel guanidine derivatives of tricyclic aryl compounds...